Today, on 21 October 2024, ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") has held an Extraordinary General Meeting 2024 (the "EGM"). Notice of the EGM and complete proposals for resolu ...
Dong-A ST (President/CEO Jae-Hun Jung, KRX:170900) announced on October 18 th that its biosimilar IMULDOSA ® (active ingredient: ustekinumab, development code DMB-3115), referencing Stelara ®, has ...